ESMO Media Releases

Cancer has a major impact on mental and physical wellbeing, researchers report at the ESMO Asia 2016 Congress in Singapore.

Ribociclib significantly improves progression-free survival in Asian women with advanced breast cancer, according to a sub-analysis of the MONALEESA-2 trial presented at the ESMO Asia 2016 Congress in Singapore.

The first data on rare sarcomas in Asian patients is presented in three studies today at the ESMO Asia 2016 Congress in Singapore

ESMO Asia is a must-attend conference for all healthcare professionals involved in the management of patients with cancer

Asian head and neck cancer patients live longer with the immunotherapy pembrolizumab than the overall population, according to a sub-analysis of the KEYNOTE-012 trial presented at the ESMO Asia 2016 Congress in Singapore

The study in over 5,500 women found that younger patients and those who had taken hormone replacement therapy (HRT) were less likely to adhere to their medicine.

Pain relief and other forms of supportive care for cancer patients are insufficient, researchers will report at the ESMO Asia 2016 Congress

Research to be presented at the ESMO Asia 2016 Congress

The ESMO Asia 2016 Congress announces its press programme today. The meeting brings together cancer experts in Singapore, from 16 to 19 December 2016

Late registration for ESMO Asia 2016 Congress ends 9 November

The 4th edition of the ESMO Symposium on Immuno-Oncology begins Friday 4 November 2016 in Lausanne, Switzerland

ESMO 2016 Congress has broken records, not only of attendance, but in terms of the quality science being presented, that will impact the practice of oncology